REPL's three largest insider shareholders as of August 29, 2026 are Fund Iv, L.P. Omega (TenPercentOwner, 9.44Mn shares), Fund Iv, L.P. Omega (TenPercentOwner, 9.44Mn shares), Robert Coffin (President Chief Rd Officer, 1.82Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Fund Iv, L.P. Omega | TenPercentOwner | 4,673,380 | 4,763,380 | 9,436,760 | 61.5% | 16 Mar, 2022 |
| 2 | Robert Coffin | President Chief Rd Officer | 1,821,872 | 0 | 1,821,872 | 11.9% | 20 May, 2024 |
| 3 | Philip Astley-Sparke | Executive Chairman | 1,362,414 | 0 | 1,362,414 | 8.9% | 24 Aug, 2026 |
| 4 | Colin Love | Chief Operating Officer | 777,345 | 0 | 777,345 | 5.1% | 20 May, 2024 |
| 5 | Sushil Patel | Chief Executive Officer | 708,151 | 0 | 708,151 | 4.6% | 12 Aug, 2026 |
| 6 | Pamela Esposito | Chief Business Officer | 263,436 | 0 | 263,436 | 1.7% | 13 Sep, 2023 |
| 7 | Konstantinos Xynos | Chief Medical Officer | 224,215 | 0 | 224,215 | 1.5% | 12 Aug, 2026 |
| 8 | Emily Luisa Hill | Chief Financial Officer | 215,852 | 0 | 215,852 | 1.4% | 19 Aug, 2026 |
| 9 | Christopher Sarchi | Chief Commercial Officer | 180,962 | 0 | 180,962 | 1.2% | 03 Jun, 2026 |
| 10 | Tanya Lewis | Chief Dev. Op. Officer | 135,293 | 0 | 135,293 | 0.9% | 15 Jun, 2023 |
| 11 | Jean M. Franchi | Chief Financial Officer | 128,748 | 0 | 128,748 | 0.8% | 18 May, 2023 |
| 12 | Andrew Schwendenman | Chief Accounting Officer | 99,425 | 0 | 99,425 | 0.6% | 12 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 20 Aug, 2026 | Philip Astley-Sparke | Director | Disposed G | 50,000 | $0.00 | $0 | 1,362,414 | Direct |
| 17 Aug, 2026 | Emily Luisa Hill | Chief Financial Officer | Disposed S | 9,256 | $14.28 | $132.18K | 215,852 | Direct |
| 10 Aug, 2026 | Sushil Patel | Chief Executive Officer | Disposed S | 39,341 | $12.97 | $510.25K | 708,151 | Direct |
| 10 Aug, 2026 | Konstantinos Xynos | Chief Medical Officer | Disposed S | 11,447 | $12.97 | $148.47K | 224,215 | Direct |
| 10 Aug, 2026 | Andrew Schwendenman | Chief Accounting Officer | Disposed S | 7,632 | $12.97 | $98.99K | 99,425 | Direct |
| 10 Aug, 2026 | Emily Luisa Hill | Chief Financial Officer | Disposed S | 11,448 | $12.97 | $148.48K | 225,108 | Direct |
| 01 Jun, 2026 | Christopher Sarchi | Chief Commercial Officer | Disposed S | 12,000 | $9.24 | $110.88K | 180,962 | Direct |
| 18 May, 2026 | Sushil Patel | Chief Executive Officer | Disposed S | 37,324 | $5.08 | $189.61K | 747,492 | Direct |
| 18 May, 2026 | Konstantinos Xynos | Chief Medical Officer | Disposed S | 14,023 | $5.08 | $71.24K | 235,662 | Direct |
| 18 May, 2026 | Andrew Schwendenman | Chief Accounting Officer | Disposed S | 7,894 | $5.08 | $40.10K | 107,057 | Direct |
| 18 May, 2026 | Christopher Sarchi | Chief Commercial Officer | Disposed S | 8,626 | $5.08 | $43.82K | 192,962 | Direct |
| 18 May, 2026 | Emily Luisa Hill | Chief Financial Officer | Disposed S | 7,812 | $5.08 | $39.68K | 236,556 | Direct |
| 18 May, 2026 | Philip Astley-Sparke | Director | Disposed S | 17,657 | $5.08 | $89.70K | 1,412,414 | Direct |
| 01 Apr, 2026 | Konstantinos Xynos | Chief Medical Officer | Acquired A | 50,000 | $0.00 | $0 | 249,685 | Direct |
| 01 Apr, 2026 | Andrew Schwendenman | Chief Accounting Officer | Disposed A | 36,667 | $0.00 | $0 | 114,951 | Direct |
| 01 Apr, 2026 | Veleka Peeples-Dyer | Director | Acquired A | 44,500 | $0.00 | $0 | 44,500 | Direct |
| 01 Apr, 2026 | Andrew Schwendenman | Chief Accounting Officer | Disposed A | 36,667 | $0.00 | $0 | 114,951 | Direct |
| 01 Apr, 2026 | Kapil Dhingra | Director | Acquired A | 44,500 | $0.00 | $0 | 44,500 | Direct |
| 01 Apr, 2026 | Andrew Schwendenman | Chief Accounting Officer | Disposed A | 36,667 | $0.00 | $0 | 114,951 | Direct |
| 01 Apr, 2026 | Konstantinos Xynos | Chief Medical Officer | Acquired A | 50,000 | $0.00 | $0 | 249,685 | Direct |